Rodney, it seems to me, is a practical sort of person as evidenced by his repeated question about which cough mixture he should use. It seems he is also correct in his impression from what he has read, that cough mixtures are a waste of time and money. And all the discussion about the proven biological effects of the components don't change the fact that, on the coalface, in practical everyday life, they are almost useless.
The research for the ingredients contained within various cough medicines is similar to what I summarized for
dextromethorphan - animal studies and human studies using induced and other types of cough. And they are mostly positive and form the bulk of the information that leads to FDA approval for that indication. These studies do include specific formulations of cough medicines, not just single ingredient studies. And I think they correspond to your comment about "proven biological effects of the components". Then we have clinical studies where cough medicines are tested in various clinical scenarios, which I think corresponds to your statement about "practical everyday life", with more heterogeneous results.
What information you look for to guide your opinion depends upon the question you are asking. If you have a cough associated with a viral infection and you are having trouble sleeping at night, you are interested in a study that shows whether or not, if you actually take the medication at that time for that indication, you are likely to get more sleep. You are less interested in studies which look at the results in people that may or may not have taken the medication (clinical studies are analyzed as intention-to-treat - the outcomes in the treatment arms are analyzed as though everyone took the medication (or placebo) even though it is rare for everyone to use the medicine as directed and many times a large portion of the group does not use the medication at all (this does make it more likely to get negative results, but there are good reasons to do it this way)) since you know that you are actually going to take the medication in the recommended amounts. You are also less interested in studies where people took the medication for reasons other than your own. And you are less interested in studies where the outcome measured was not sleep or satisfaction, but something like cough sound volume.
On the other hand, if you are a group of experts charged with making public policy recommendations, you are more interested in studies that look at how people use the medication in the real world, taking into consideration that people will not take the medication or will not follow recommended dosing, or they will use it for conditions for which it is not recommended. Measures of change in discomfort, disease, disability or death are more important than changes in dissatisfaction. And potential harm from mis-use is a serious consideration.
Both you and the experts are probably concerned with cost and ease of use, but as an individual, you are better able to make that determination for yourself, and research or the opinions of others isn't really relevant.
Why we see a disconnect between what the research shows (lots of evidence that cough medicines are efficacious and effective) and what you think the various experts are saying is that you and Rodney have provided links to statements that deal with somewhat isolated situations (some quotes taken out of context give the false impression that they refer to all the evidence), and that the priorities of the expert groups are different from the priorities of an individual. For example, you refer to the CPG from the Royal Children's Hospital, but that is a statement about whether cough medicines
treat cough, not whether they relieve cough, and clinical evidence for children should not automatically be extrapolated to adults (and vice versa). The issue about treating vs. relieving coughs has come up several times, and I agree that it is important to recognize that people can be confused. Expert groups tend to be very conservative when it comes to recommending treatment that addresses only dissatisfaction or mild discomfort. And that is really all that we are talking about addressing with OTC cough medicines.
We can look at the
review published in the BMJ as an example, especially because I suspect many of the statements of opinion that you and Rodney have presented as evidence stem from that source. Please note that this review only covers acute cough due to URTI in adults.
This is a summary of the results:
Two trials of codeine showed no effect above placebo. One trial of DM showed effect above placebo and one did not. One trial of moguistiene showed effect above placebo. One trial of guaifenesin showed effect above placebo and one trial did not. One trial of a mucolytic showed effect above placebo. One trial of an antihistamine-decongestant combination showed effect above placebo and one did not. Three trials of mixed-preparations showed effect above placebo. Two trials of terfenadine (note this is a different type of antihistamine from those used in cough and cold medicines with a different mechanism of action) showed no effect above placebo.
The effect sizes varied. Keep in mind that the placebo effect in cough is large - around 1/4 to 1/3. So a small effect above placebo still represents a moderate difference, although we cannot tell how much of that is subjective.
I need to digress again to talk about Type I (false-positive) and Type II (false negative) error. Medical research is very conservative. The bar is set, by convention at 95% for a Type I error. We are trying to avoid coming to any hasty conclusions in the drive to make the best recommendations. This means that we will reject as "positive" effects that would only occur one time out of 19 by chance. This makes the chance that we come up with a false postive low and gives a measure of confidence in our results. But of course, this makes it easy for us to reject a lot of medications that may be effective (false negative). We measure Type II error by looking at the power of a study - what is the chance that we won't miss a true effect. If you look at medical research, especially less recent research, you rarely see power calculations. I think part of this is because power is more difficult to grasp intuitively and is more difficult to calculate as it may include values that have to be estimated (if done, it is usually done before the study is carried out in order to estimate the necessary sample size), and because accepting a false premise is considered a worse offense than rejecting a true premise. By convention, the usual level is chosen to be 80% for this kind of study, which leaves a one in five chance that you will miss a positive effect. However, that power level is rarely achieved. In particular, in the studies referenced for the review, the power of the studies was less than 50%, making it
more likely than not that a clinically significant effect could be missed.
Ignoring what anyone else has to say about these results, there are several reasonable conclusions that could be drawn from this evidence depending upon how you wish to present the results.
There is reasonable evidence that the following cough medicines are effective in reducing cough symptoms in adults with acute URTI - dextromethorphan, moguistiene, guaifenesin, a mucolytic, an antihistamine-decongestant combination, and multi-ingredient cough medicines. There is weak evidence that the following cough medicines are ineffective in reducing cough symptoms in adults with acute URTI - codeine, terfenadine. The effect sizes vary in clinical significance from small to large.
There is conflicting evidence that the following medications are effective in reducing cough symptoms in adults with acute URTI - dextromethorphan, guaifenesin, anti-histamine-decongestant combinations. There is reasonable evidence for the effect of multi-ingredient cough medicines and a mucolytic. There is weak evidence that codeine and terfenadine are ineffective. The effect sizes vary in clinical significance from small to large.
There is no strong evidence that any of the tested cough medicines have a large, clinically significant effect on cough symptoms in adults with acute URTI.
There is weak to moderate evidence that some cough medicines have a large, clinically significant effect on cough symptoms in adults with URTI.
There is weak to moderate evidence that some cough medicines do not have a moderate to large clinically significant effect on cough symptoms in adults with URTI.
All the above conclusions are valid interpretations of the results presented (I could do more, but I hope you see my point). And what it really indicates is that one cannot make blanket statements about whether or not cough medicines are effective. They are effective for some purposes and not for others, depending upon which particular preparation you are considering. And the negative studies are not strong enough to prove they are ineffective by themselves. Unless you provide specific evidence of equal or greater quality that counteracts the positive evidence, the negative evidence serves to qualify the positive, rather than negate it.
Sure they where obtained via media reporters who so often screw these things up. But above I have given you a quote from physicians at the Royal Children's Hospital to both patients and to Family Physicians. This advice is based on best evidence.
The quotes you provided were unreferenced. There was no indication given as to what evidence was used for the advice. Given the source, it is reasonable to assume that good evidence was used. But since none of what they said contradicted the evidence that I provided, it doesn't really matter. It also doesn’t serve as a comprehensive survey since it only addressed isolated situations.
I don't think your responses to those quotes or to the practical advice offered by that major public hospital do anything to advance your cause.
regards,
BillyJoe
It wasn't intended to advance my cause. It was intended to point out that it did nothing to counteract my cause. The evidence on the effectiveness of cough medicine cannot be summarized in a single sentence and it is more incorrect to say that they are not effective than it is to say that they are effective. And taking into consideration the strength of the evidence, the size of effect, and that they provide symptom relief rather than disease modification, it is a matter of personal opinion whether they are worth the expense. But the buying patterns of consumers suggest that most consider it worth it (i.e. people are willing to spend a little money on relief of symptoms (not knowing how many are confused about the relief/treatment issue)).
Linda